Leadership

with the voice of experience

Management Team

Medical and Executive Advisors

Dr. Jack Cochran, MD, FACS has 25 years of leadership experience at Kaiser Permanente and served as Executive Director of the Permanente Federation from 2007 to 2015. He also served as medical director, president, and chairman of the board of the Colorado Permanente Medical Group, beginning his career at CPMG in 1990. He currently serves on the board of directors for the Alliance of Community Health Plans and the advisory board for the UCSF Global Health Group.

Dr. Cochran was named one of the 50 Most Influential Physician Executives in Healthcare in the eighth annual survey published by Modern Healthcare/Modern Physician in May 2012. He has also co-authored The Doctor Crisis: How Physicians Can, and Must, Lead the Way to Better Health Care. For more than 20 years, Dr. Cochran has volunteered his reconstructive surgery and consulting services in Third World countries, aiding underserved populations in Nicaragua, the Philippines, Ecuador, Tanzania and Nepal.

He is the former president of the Consortium for Community Centered Comprehensive Child Care (C6), a foundation that has built hospitals in East Africa.

He participated in implementing many of the priorities called for in health reform, including Kaiser Permanente’s electronic health record, the largest successful non-government clinical information systems deployment in the world.

Dr. Cochran earned his medical degree from the University of Colorado and served residencies at Stanford University Medical Center and the University of Wisconsin Hospital. He is board certified in otolaryngology (head and neck surgery) and in plastic and reconstructive surgery.

Dr. White, an interventional cardiologist, is the Heart Failure Medical Director for the John Muir Health System. He maintains an active practice while also conducting numerous research projects supported by grants from NASA, the American Heart Association and the National Institutes of Health.

Dr. White is a key member of the Executive Committee of the American College of Cardiology’s Hospital to Home initiative, a national quality improvement program working to reduce cardiovascular related hospital re-admissions and improve the transition of patients after hospitalizations for cardiovascular disease.

He is passionate about advising startups developing innovative medical devices and solutions for cardiovascular diseases.

Dr. Behzad Nadji has enjoyed a career spanning over twenty five years in Networks Design and Architecture, Operations & Business Support Systems and Mobile Application Development fields. He started from co-founding and building startups to managing large multinational teams in various area of software Systems Design and Development, Telecom, Services development, IT Consolidation, Data Center Architecture and Consolidation, and Internal/Hybrid Cloud and Self Servicing portals. As the senior VP of AT&T and a corporate officer, he led the prestigious AT&T Lab (formerly Bell Labs) Research organization involved in Network, Software and Speech technologies research. He also created and managed the Enterprise Architecture organization, which defined the overall AT&T Operations Support Systems (OSS/BSS), Network and IT architecture blueprints. After the merger with SBC, Dr. Nadji was in charge of Network Architecture, Design, Development and Certification for the entire AT&T/SBC Network. He also headed new technology introduction into AT&T network and software systems and managed the AT&T Strategic Venture Investment Fund. Dr. Nadji also served as Senior VP and VP at Excite@Home and BlackBerry for many years managing large multinational software development teams. At BlackBerry, he consolidated and managed the internal and customer facing Business and Corporate systems (CIO Functions), including Mobile application development, Financials and HR systems, Sales and Marketing systems, Care and Sales Portals, Enterprise Data Warehouse, Information Management/ Reporting systems, Customer Care Systems, Ticketing Systems, Network Management, Monitoring and Metering Systems and various proprietary internal systems. Throughout his career, Dr. Nadji has served on a number of advisory boards and board of directors, including the IBM Autonomic computing Advisory Board, HP Technical Advisory Board, and University of Southern California EE technical Advisory Board and the TeleManagement Forum Board of Directors. He is the recipient of AT&T’s prestigious “Science and Technology Medal”, as well as over 20 other awards in the area of business innovation, architecture, and software development excellence. A senior member of IEEE, he holds over 10 issued technical patents and several others that are in progress. He is currently the founder of the Global Business and Technology Consulting firm which is involved in

Dr. Nadji also served as Senior VP and VP at Excite@Home and BlackBerry for many years managing large multinational software development teams. At BlackBerry, he consolidated and managed the internal and customer facing Business and Corporate systems (CIO Functions), including Mobile application development, Financials and HR systems, Sales and Marketing systems, Care and Sales Portals, Enterprise Data Warehouse, Information Management/ Reporting systems, Customer Care Systems, Ticketing Systems, Network Management, Monitoring and Metering Systems and various proprietary internal systems. Throughout his career, Dr. Nadji has served on a number of advisory boards and board of directors, including the IBM Autonomic computing Advisory Board, HP Technical Advisory Board, and University of Southern California EE technical Advisory Board and the TeleManagement Forum Board of Directors. He is the recipient of AT&T’s prestigious “Science and Technology Medal”, as well as over 20 other awards in the area of business innovation, architecture, and software development excellence. A senior member of IEEE, he holds over 10 issued technical patents and several others that are in progress. He is currently the founder of the Global Business and Technology Consulting firm which is involved in

Throughout his career, Dr. Nadji has served on a number of advisory boards and board of directors, including the IBM Autonomic computing Advisory Board, HP Technical Advisory Board, and University of Southern California EE technical Advisory Board and the TeleManagement Forum Board of Directors. He is the recipient of AT&T’s prestigious “Science and Technology Medal”, as well as over 20 other awards in the area of business innovation, architecture, and software development excellence. A senior member of IEEE, he holds over 10 issued technical patents and several others that are in progress. He is currently the founder of the Global Business and Technology Consulting firm which is involved in

He is currently the founder of the Global Business and Technology Consulting firm which is involved in technical assessment of corporate M&A activities as well as advising companies with their Architecture, Systems and Software Engineering practices.

Board of Directors

Steve founded MVM Life Science Partners in 1997. Prior to setting up MVM, he was responsible for early-stage healthcare investments at Saunders, Karp & Megrue in New York City. Between 1988 and 1993 Steve was an Investigator of the Howard Hughes Medical Institute at the Boyer Center for Molecular Medicine at Yale, where he was also an Associate Professor of Medicine and Genetics. He has published more than 50 papers on the molecular genetics of human disease.

Steve has been involved in starting several US biotechnology companies and was acting CEO at UpToDate In Medicine in Wellesley, Mass. He practiced medicine at the John Radcliffe Hospital, Churchill Hospital, Guys Hospital, St Thomas’s Hospital, Hammersmith Hospital and the Institute of Neurology, Queen Square before taking up research into molecular genetics at Oxford University. He has a degree in Natural Sciences from Cambridge and a Doctorate in medicine from Oxford and is a member of the Royal College of Physicians of England.

Steve is a member of the boards of Ambio, Inc., Cheetah Medical, Inc., Providence Medical Technology, Inc., Pulmagen Therapeutics Ltd and Zipline Medical, Inc. He was previously a director of Beacon Endoscopic Ltd, BioVex Group, Inc., Cara Therapeutics, Inc., Clavis Pharma ASA, Domantis Ltd, Gendaq Ltd, Momenta Pharmaceuticals, Inc., New Chemical Entities, Inc., Nova Science Ltd, Sangamo Biosciences, Inc., UpToDate, Inc., Xention Ltd and Vascular Pathways, Inc.

Bob White joined EW as an Operating Partner in 2019 after nearly 30 years leading early-stage companies and Fortune 500 business units in the medical technology sector, including most recently as President and CEO of Entellus Medical, an EW portfolio company acquired by Stryker for ~$660 million.

Mr. White has played a key role in furthering EW’s medical device investment practice. He served on the Board of Directors for Cardiva Medical before it was acquired by Haemonetics, currently serves on the Board of Vital Connect and as the Executive Chairman of the Board of TissueTech.

As mentioned, prior to EW Mr. White was President and Chief Executive Officer of Entellus Medical, driving the business to treat over 250,000 patients suffering from chronic sinusitis, Eustachian tube dysfunction and airway obstruction. In 2018 Mr. White was recognized as a finalist of the Ernst & Young Entrepreneur of the Year and he received the YPO Global Innovation Award.

Prior to Entellus, Mr. White was the President and Chief Executive Officer of TYRX, Inc. which specialized in commercializing innovative, implantable combination drug and device products focused on infection control until TYRX was acquired by Medtronic in 2014. Along the way TYRX was named to the Fierce Medical Devices “Fierce 15”, designating it as one of the leading medical device and diagnostic companies.

Before joining TYRX, Mr. White held several executive positions with Medtronic including serving as President of Physio Control, Vice President of Commercial Operations of the Cardiac Rhythm Disease Management business, and President of Kyphon following Medtronic’s acquisition of the spinal treatment business. Earlier in his career, he held leadership positions in business development, international sales and marketing, operations, and general management with Instromedix/Life Watch, Eli Lilly, IVAC/Alaris Medical, and General Electric.

Mr. White currently also serves as a Director on the Board of Atricure Inc. (NASDAQ: ATRC) and Director on the Board of privately held Cardiac Dimensions Pty. Ltd. Two other companies for which he actively served as a Director were acquired for significant premiums including Novadaq Technologies and privately held Hyperbranch Medical Technology.

Mr. White holds a Bachelor of Science degree in Aerospace Engineering from the University of Missouri-Rolla and a Master of Business Administration degree from Cornell University.

Peter brings more than 20 years of experience in the medical device and biopharmaceutical industry.

Prior to VCI, Peter served as the U.S. commercial vice president at Cordis.  In addition, Peter has held senior sales roles at St. Jude Medical Corporation, AGA Medical Corporation and Covidien Healthcare (formerly Tyco Healthcare), among other leading health care companies.

Peter has proven experience driving commercial growth; building and leading diverse organizations of over 300 individuals, managing revenues exceeding $500 M and representing product offerings with C-level administrators. Peter received a Bachelor of Arts in Economics from the University of Massachusetts and completed the Columbia University Executive Management Program

Nersi is a world class information and medical technologist with 37 years of experience in bringing life changing technologies to widespread commercial use. Nersi has also made contributions to the Medical and Information Technology worlds as an entrepreneur, a CEO and a venture capitalist.

Nersi has brought new communication standards and semiconductor solutions to market including Gigabit local area networking (LAN), WiFi and digital mass storage as well as designing highly integrated System-on-Chip (SoC) solutions.  Hundreds of millions of these parts are in use today and have brought 10’s of billions of dollars of revenue to NASDAQ:MRVL where he pioneered these technologies as the founding vice president of Signal Processing Technology.

After 24 years of purely tech achievements, Nersi founded VitalConnect in 2011 to bring these technologies to digital healthcare by developing the world’s leading patient monitoring solution.  VitalConnect’s VitalPatch®  and Vista Solution® benefit from his expertise in semiconductor chip and SoC design, high volume manufacturing, electronics, signal processing, machine learning, AI and cloud computing.

Nersi has and is serving in several public, private and nonprofit boards. He earned a doctorate in electrical engineering from the University of Colorado and has been awarded nine U.S. patents.

Antonius Kufferath is a partner in Acacia, an investment partnership that invests in private and public equities worldwide. He is also a member of the investment team at Ruane, Cunniff & Goldfarb, the New York-based investment firm known for managing the Sequoia mutual fund.

Mr. Kufferath joined Acacia and Ruane, Cunniff in 2014 and focuses on investing in industrial and technology companies in Europe and the Americas. Earlier in his career, Mr. Kufferath worked in strategy & business development for a public US industrial company, and as a consultant for a leading strategy consulting firm.

Mr. Kufferath received an M.Phil. with distinction in Modern Chinese Studies from Oxford University. He also received a B.S.F.S. magna cum laude, Phi Beta Kappa, in International Relations from Georgetown University. A native German speaker, he is also fluent in Portuguese and French. He has been published in the Financial Times and the Frankfurter Allgemeine Zeitung.

George B. Moore is a partner of Juniper Investment Company, a New York-based private investment firm that invests as an active, long-term, lead shareholder in a concentrated portfolio of US public equity securities. Juniper’s healthcare investments have included Artivion (AORT), Transcat (TRNS) and Theragenics.

Mr. Moore has over 25 years of public and private equity investing experience. During this time has been responsible for sourcing, due diligence, investment approval, execution, value-add and board oversight of numerous public and private company investments. This experience includes extensive transactional expertise, including mergers and tuck-in acquisitions, IPOs, debt and equity offerings, and bank financings. Prior to joining Juniper, Mr. Moore was a partner of Quilvest Private Equity, managing partner of Bristlecone LLC, vice president of Hoak Capital and analyst at Citicorp Venture Capital. Mr. Moore received his B.A. from Colby College and his M.B.A. from Columbia Business School.

Thomas A. Saunders III was president of Ivor & Co., LLC and the Ivor Foundation, a private investment firm and family foundation respectively.

He began his investment banking career at Morgan Stanley where he was a managing director, headed the firm’s syndicate and capital market group and ultimately became Chairman of its $2.2 billion private equity fund. After leaving Morgan Stanley in 1989, he founded the private equity firm, Saunders Karp & Megrue, which merged in 2005 with Apax Partners, LP, a private equity firm headquartered in London.

An active private equity investor, Mr. Saunders was a Senior Advisor to a number of investment funds including Metalmark Capital, Citi’s Old Lane Funds, Roundtable Partners, Parallel Partners, Goode Holdings and Blackrock‘s private equity fund of funds. In addition, he served on the Boards of Directors of the publicly traded Dollar Tree, Inc., where he was Lead Director, and Hibbett Sporting Goods, Inc.

Mr. Saunders had a strong knowledge of the healthcare industry, having managed portfolio companies including UpToDate, Inc— a medical research service for physicians and hospitals. He currently served as a Trustee of the Cold Spring Harbor Laboratory, which has been home to eight Nobel Prize winners and has been consistently ranked as the No. 1 scientific research institution worldwide for its molecular biology and genetic research impact, as measured by science publisher Thomson Reuters.

Throughout his laudable career, Mr. Saunders had been involved in some of the most noteworthy financial transactions in history. These include, raising $3.8 billion of common equity for AT&T during an eighteen month period beginning in 1981, the largest amount of equity raised for a single company at the time. The underwriters’ option, known as the “Greenshoe”, was employed for the first time in a Fortune 100 company equity offering and has become a standard feature of public equity offerings. In 1980, Mr. Saunders managed the initial public offering (IPO) of Apple Computer. He led the team providing financial advice to AT&T on its $150 billion divestiture of the Bell System operating companies in 1984, the largest restructuring in history. This divestiture was the precursor to the present structure of the telecommunications industry in the United States.

Mr. Saunders’ philanthropic interests focused principally on higher education, historic preservation and the arts. He was a member of the Trustees’ Council of the National Gallery of Art in Washington, DC. He was the former chairman of the University of Virginia Darden School Foundation. He had been a member of the Boards of Visitors of the University of Virginia and the Virginia Military Institute. From 1995-2000, he was the National Co-Chairman of the University of Virginia’s $1.4 billion capital campaign.

Mr. Saunders received his BSEE from the Virginia Military Institute in 1958 and an MBA from the University of Virginia Darden School in 1967.

Mr. Saunders passed away September 9, 2022. VitalConnect honors his memory and commitment to innovation. He was the VitalConnect Lead Director from 2014 to 2023.